News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GOTTSCHALK ADRIAN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
4
| GOTTSCHALK ADRIAN (CEO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Gifted 63,000 shares
@ $0
Gifted 63,000 shares
@ $0 |
|
| 05/31/2023 |
4
| GOTTSCHALK ADRIAN (CEO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Gifted 300,000 shares
@ $0 |
|
| 02/22/2023 |
4
| GOTTSCHALK ADRIAN (CEO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Gifted 123,479 shares
@ $0
Gifted 123,479 shares
@ $0
Acquired 4,371 shares
@ $0
Disposed of 4,371 shares
@ $0
Gifted 4,371 shares
@ $0
Gifted 4,371 shares
@ $0
Disposed of 184,939 shares
@ $0
Acquired 184,939 shares
@ $0 |
|
| 01/30/2023 |
4
| GOTTSCHALK ADRIAN (CEO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 280,000 options to buy
@ $8.38, valued at
$2.3M
|
|
| 09/19/2022 |
4
| GOTTSCHALK ADRIAN (CEO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Exercised 40,000 options to buy
@ $0.54, valued at
$21.6k
|
|
| 01/28/2022 |
4
| GOTTSCHALK ADRIAN (CEO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 440,000 options to buy
@ $14.87, valued at
$6.5M
|
|
| 08/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| GOTTSCHALK ADRIAN (See Remarks) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 300,000 options to buy
@ $16.63, valued at
$5M
|
|
| 10/29/2020 |
4
| GOTTSCHALK ADRIAN (See Remarks) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Converted 25,225 shares
@ $0
Converted 18,018 convertible preferred
@ $0
Converted 7,207 convertible preferred
@ $0 |
|
|
|